Paremyd
| Paremyd | |
|---|---|
| DOSAGE | 1-2 gtts QD |
| GENERIC | hydroxyamphetamine 1%, tropicamide 0.25% |
| SIZE | 15mL |
| INDICATIONS | Cycloplegia, Mydriasis |
| MECHANISM OF ACTION | Adrenergic agonist and anticholinergic |
| MICROBIOLOGY | Activates the receptors of the iris dilator to dilate the pupil, and blocks acetylcholine preventing the iris sphincter from constricting and ciliary muscle from accommodating |
| CONTRAINDICATIONS & WARNINGS | Contraindicated in patients with narrow angles or hypersensitivity to ingredients |
| PEDIATRIC USE | Safety and effectiveness in pediatric patients have not been established. |
| PREGNANCY | Category C |
| NOTE | Onset of action within 15 minutes with maximum effect within 60 minutes. Recovery beginning at 90 minutes and complete in 6 to 8 hours for most patients. PAREMYD® (hydroxyamphetamine hydrobromide, tropicamide) Solution is indicated for mydriasis in routine diagnostic procedures and in conditions where short-term pupil dilation is desired. |